Adamed Pharma S.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-06-07
Share capital
718,430,000.00 PLN
Activity description

Adamed Pharma is a Polish pharmaceutical and biotechnology company with 40 years of experience, developing and providing high-quality medicinal products, including prescription and over-the-counter drugs, dietary supplements, dermocosmetics, and medical devices. The company focuses on addressing chronic diseases across various therapeutic areas and holds 256 patents in the pharmaceutical field. Its products are available in dozens of countries worldwide, with an extensive portfolio of approximately 900 items.

Registered address
ul. Mariana Adamkiewicza 6A, 05-152 Pieńków, Poland
Branches
  • ul. Szkolna 33, 95-054 Ksawerów
  • ul. Marszałka Józefa Piłsudskiego 5, 95-200 Pabianice
  • ul. Klonowa 44J, 05-830 Kajetany
  • ul. Karowa 31a, 00-324 Warszawa
Email
Phone
Social media
Electronic delivery address
AE:PL-38079-44574-TIEUH-19

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$22,353,304

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 3 days late). All were audited by a statutory auditor.

  • 202530/06/2026
  • 202425/06/2025
  • 202304/07/2024
  • 202203/07/2023
  • 202118/07/2022
  • 202017/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing99 / 24,649
Top <1%
Voivodeship · Mazowieckie148 / 77,195
Top <1%
Country · Poland331 / 298,026
Top <1%

Results vs industry

Revenue
This companyUSD 541.93mMedianUSD 917.74kAverageUSD 25.93m
Net profit
This companyUSD 54.10mMedianUSD 14.44kAverageUSD 2.78m
Operating costs
This companyUSD 401.38mMedianUSD 860.03kAverageUSD 21.46m
Assets
This companyUSD 854.81mMedianUSD 911.84kAverageUSD 31.78m

Websites

The company has 7 websites, including one version for a foreign market (United Kingdom). Most of them run on WordPress. The company measures traffic with Google Analytics and uses the Meta advertising pixel (Facebook, Instagram).

  • adamed.comAdamed – tu polska innowacja ma swój początek
    Google AdsGoogle AnalyticsGoogle Tag Manager
  • WordPress 3.7Google AnalyticsGoogle Tag ManagerApache
  • adamedsuperleague.plAdamed Super League – Adamed Super League
    WordPress 6.7LinkedIn AdsGoogle Tag ManagerMeta PixelNginx

Public procurement

The company is the contractor in 5 public sector contracts, worth USD 3.99k in total. They were signed with 5 public buyers.

SubjectAmount
Donation of medicinal products
$1,105
Antibacterial filters M03.1.003
$1,757
Medical
$49.01

Trademarks

The company holds 445 active trademarks registered with the Polish Patent Office. 56 applications are pending. 72 marks have expired or were not registered. The first mark was filed in 1960.

MarkNumberClassesStatusProtected until
ZAHRON TRIO (word)Z.5998775Protected Mar 23, 2036
TIOXA (word)Z.5977665Protected Feb 10, 2036
BROTRIM (word)Z.5968145Protected Jan 21, 2036
TIOTRIX (word)Z.5968115Protected Jan 21, 2036
DUOTRIM (word)Z.5937045Protected Nov 13, 2035
MarkProtected until
ZAHRON TRIO (word)Mar 23, 2036
TIOXA (word)Feb 10, 2036
BROTRIM (word)Jan 21, 2036
TIOTRIX (word)Jan 21, 2036
DUOTRIM (word)Nov 13, 2035

Job offers

The company has its own careers page: adamed.com/kariera.

Authorized Representatives

Karolina Anna Czekaj age 47 – Management Board Member
Anna Maria Terlecka age 48 – Management Board Member
Bartłomiej Stanisław Rodawski age 50 – Management Board Member
Grzegorz Ludwik Chełmicki age 52 – Management Board Member
Małgorzata Guzy age 62 – Attorney-in-fact (joint)

Manner of representation

Declarations of will on behalf of the company require the joint action of two members of the management board, or one member of the management board jointly with a commercial proxy.

Supervisory board

Karolina Adamkiewicz age 33 – Supervisory Board Member
Michał Maciej Adamkiewicz age 28 – Supervisory Board Member
Małgorzata Adamkiewicz age 60 – Supervisory Board Member

Beneficial owners

Person

Subsidiaries

NameStake
Adpharma sp. z o.o.
100%

Sanctions and PEP

Sanctions

No matches (EU, UN, US, UK, MSWiA, World Bank)

PEP

No matches

Bank accounts

Registered as a VAT taxpayer on 2003-12-31.

  • mBank
    39 1140 1010 0000 5590 0900 1024
  • BNP Paribas Bank Polska
    83 1600 1143 0003 0602 3319 7027
  • Bank Gospodarstwa Krajowego
    Bank Gospodarstwa Krajowego
    85 1130 1163 0014 7151 4920 0003

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$4.4M
Buildings and premises
$83M

MSiG notices

7 notices recorded in the Court and Commercial Gazette (MSiG).

Publication dateEvent
May 28, 2026Shareholders' meeting convened
Sep 24, 2021Merger registered
Jun 5, 2019Commercial Companies Code notice
Jan 3, 2019Merger plan
Dec 10, 2018Commercial Companies Code notice

Public aid

39 public aid cases recorded, with a total value of $54,955,630.

PurposeGross amount
Aid for research and development projects: industrial research
$1M
Aid for research and development projects: industrial research
$341.4K
Aid for research and development projects: experimental development
$294.1K

European Funds

5 projects co-financed from European Funds recorded, with total EU co-financing of $5,487,068.

ProjectEU co-financing
Development and implementation of an innovative medicinal product in the form of a chewable tablet containing a second-generation antipsychotic substance.
$2.2M
LabGears: development and implementation of a web application for managing and analysing research and development data
$321.1K
„Opracowanie i wdrożenie nowoczesnej postaci leku o łatwej aplikacji, hamującego łysienie androgenowe oraz stymulującego odrost włosów zarówno u kobiet, jak i u mężczyzn”
$149K

Competitors

Name
Teva Operations Poland sp. z o.o.
Bausch Health Poland sp. z o.o.
USP Zdrowie sp. z o.o.
Aflofarm Farmacja Polska sp. z o.o.
Biofarm sp. z o.o.
Zentiva Polska sp. z o.o.
Farmak International sp. z o.o.
Synoptis Pharma sp. z o.o.
Polfarmex S.A.
Solinea sp. z o.o.

Change history

DateEvent
2018-07-02Address change
2018-07-02Share capital reduction
2018-07-02Name change
2011-08-26Share capital increase
2009-10-06Share capital reduction

FAQ

Last updated: 2026-07-28